Brand name – Olanib
Generic name – Olaparib
Manufacturer – Everest
Strength – 150mg/50mg
Dosage – Tablet
Composition – Olaparib
Indication – Ovarian Cancer
Storage – at room temperature
Overview Of Olanib 150mg Tablet
Olanib 150mg tablets (Olanib 50mg) is a target therapy medication. It is used in the treatment of ovarian cancer along with fallopian and peritoneal cancers. In addition, it is also used to treat breast cancer and prostate cancer in men. The generic name of this medication is Olaparib and it is a potent PARP inhibitor.
Olanib tablets inhibit the function of PARP enzymes. PARP stands for poly ADP-ribose polymerase enzymes that are needed for basic cellular functions like DNA transcription and repair. As Olanib inhibits this enzyme it consequently leads to the accumulation of toxic DNA damage. This furthermore leads to genomic instability and triggers cell death. Also, it increases the formation of the PARP-DNA complex which stops the growth of cancerous cells.
Usage Of Olanib
Olanib 50mg (or 150mg) tablets are prescription based. It is used for the treatment of ovarian, peritoneal, fallopian, and breast cancer. The doctor decides the dose and length of the treatment depending on the type and stage of cancer. It is recommended to follow all the advice given thoroughly. Inform the doctor about all the prior medical conditions and medicines you take. It is an oral medication that can be taken with or without food however avoid Seville oranges and grapefruit as they can increase the side effects.
- With medicines
Olanib tablets can interact with some other prescription and non-prescription medicines and interfere with each other’s workings or increase the side effects. Inform your doctor if you have any of these medicines –
- With disease
Some diseases may show interactions with. Hence, consult your doctor if you have any of these conditions –
- With alcohol
It is advisable to avoid alcohol with Olanib 150mg and 50mg as their interactions are still unknown.
Olanib 150mg (50mg) tablets should not be given to patients who have allergic responses to it. Also, avoid pregnancy and breastfeeding during the treatment.